Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and β-thalassemia

Biology of Blood and Marrow Transplantation

Volumn 9, Issue 8, 2003, Pages 519-528

  Iannone, Robert ^a,f   Casella, James F ^a   Fuchs, Ephraim J ^a   Chen, Allen R ^a   Jones, Richard J ^a   Woolfrey, Ann ^b   Amylon, Michael ^c   Sullivan, Keith M ^d   Storb, Rainer F ^b   Walters, Mark C ^e  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e CHILDREN S HOSPITAL OAKLAND   (United States)

^f CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

Nonmyeloablative bone marrow transplantation; Sickle cell disease; Thalassemia

Indexed keywords

CYCLOSPORIN A; FLUDARABINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HEMOGLOBIN; HEMOGLOBIN A; LYMPHOCYTE ANTIBODY; MINOR HISTOCOMPATIBILITY ANTIGEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NARCOTIC ANALGESIC AGENT; OPIATE; PHENYTOIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; ATAXIA; AUDITORY HALLUCINATION; BETA THALASSEMIA; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DONOR; DYSARTHRIA; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOGLOBINOPATHY; HISTOCOMPATIBILITY; HLA MATCHING; HUMAN; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; LEUKOCYTE COUNT; MALE; NEUTROPHIL; PERIPHERAL BLOOD STEM CELL; RECIPIENT; RECURRENT DISEASE; RETICULOCYTOSIS; SIBLING; SICKLE CELL ANEMIA; THROMBOCYTE TRANSFUSION; VISUAL HALLUCINATION; WHOLE BODY RADIATION;

ADULT; ANEMIA, SICKLE CELL; BETA-THALASSEMIA; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; FEMALE; GRAFT SURVIVAL; HEMATOPOIESIS; HUMANS; IMMUNOCOMPETENCE; KINETICS; MALE; PILOT PROJECTS; SIBLINGS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; VIDARABINE; WHOLE-BODY IRRADIATION;

EID: 12144289379     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1083-8791(03)00192-7     Document Type: Article

References (20)

1. Walters M.C. Bone marrow transplantation for sickle cell disease: where do we go from here? J Pediatr Hematol Oncol 21 1999 467-474
2. Walters M.C. Storb R. Patience M. et al. Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report Blood 95 2000 1918-1919
3. Kodish E. Lantos J. Stocking C. Singer P. A.Siegler M. Johnson F.L. Bone marrow transplantation for sickle cell disease. A study of parents' decisions N Engl J Med 325 1991 1349-1353
4. van Besien K. Koshy M. Anderson-Shaw L. et al. Allogeneic stem cell transplantation for sickle cell disease. A study of patients' decisions Bone Marrow Transplant 28 2001 545-549
5. Walters M.C. Patience M. Leisenring W. et al. Barriers to bone marrow transplantation for sickle cell anemia Biol Blood Marrow Transplant 2 1996 100-104
6. Storb R. Yu C. Barnett T. et al. Stable mixed hematopoietic chimerism in DLA-identical littermate dogs given sublethal total body irradiation before and pharmacological immunosuppression after marrow transplantation Blood 89 1997 3048-3054
7. Giralt S. Estey E. Albitar M. et al. Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy Blood 89 1997 4531-4536
8. Khouri I.F. Keating M. Korbling M. et al. Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies J Clin Oncol 16 1998 2817-2824
9. Slavin S. Nagler A. Naparstek E. et al. Nonmyeloablative stem cell transplantation and cell therapy as an alternative to conventional bone marrow transplantation with lethal cytoreduction for the treatment of malignant and nonmalignant hematologic diseases Blood 91 1998 756-763
10. Niederwieser D. Maris M. Shizuru J. et al. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases Blood 101 2003 1620-1629
11. Iannone R. Luznik L. Engstron L.W. et al. Effects of mixed hematopoietic chimerism in a mouse model of bone marrow transplantation for sickle cell anemia Blood 97 2001 3960-3965
12. Kean L.S. Durham M.M. Adams A.B. et al. A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility-mismatched bone marrow transplant Blood 99 2001 1840-1849
13. Walters M.C. Patience M. Leisenring W. et al. Stable mixed hematopoietic chimerism after bone marrow transplantation for sickle cell anemia Biol Blood Marrow Transplant 12 2001 665-673
14. Andreani M. Manna M. Lucarelli G. et al. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia Blood 87 1996 3494-3499
15. Hawkins A.L. Jones R.J. Zehnbauer B.A. et al. Fluorescence in-situ hybridization to determine engraftment status after murine bone marrow transplant Cancer Genet Cytogenet 64 1992 145-148
16. Shulman H. Wells D. Gooley T. Myerson D. Bryant E. Loken M. The biological significance of rare peripheral blasts after hematopoietic stem cell transplant is predicted by multidimensional flow cytometry Am J Clin Pathol 112 1999 513-523
17. Sandmaier B.M. Maloney D.G. Hegenbart U. et al. Nonmyeloablative conditioning for HLA-identical related allografts for hematologic malignancies [abstract] Blood 96 2000 479a
18. Krishnamurti L. Blazar B.R. Wagner J.E. Bone marrow transplantation without myeloablation for sickle cell disease N Engl J Med 344 2001 68
19. Schleuning M. Stoetzer O. Waterhouse C. Schlemmer M. Ledderose G. Kolb H.J. Hematopoietic stem cell transplantation after reduced-intensity conditioning for sickle cell disease Exp Hematol 30 2002 7-10
20. van Besien K. Bartholomew A. Stock W. et al. Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease Bone Marrow Transplant 26 2000 445-449